Nigeria Clears Ebola?

After nearly two dozen cases of the deadly disease, Africa’s most populous country appears to have stopped the virus in its tracks.

Written byJef Akst
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Lagos, NigeriaFLICKR, ROBERTAfter reports started appearing that a 40-year-old man in Nigeria died of Ebola in July, health officials were concerned that the deadly virus was spreading. But according to an announcement made yesterday (September 30) by the US Centers for Disease Control and Prevention (CDC), the coordinated efforts of doctors and health-care workers in Nigeria has contained the virus, with no new cases reported since August 31.

“For those who say it’s hopeless, this is an antidote—you can control Ebola,” CDC Director Thomas Frieden told The New York Times (NYT). All people in Nigeria known to have been infected with the virus have either died or recovered, with an impressive cure rate of 60 percent, NYT reported, and nearly everyone who had contact with an infected patient has cleared the 21-day incubation period.

Meanwhile, however, the epidemic rages on in Guinea, Liberia, and Sierra Leone, where the virus has killed more than 3,000 people in the last few months. These countries are less equipped than the populous Nigeria to fight the disease. The country’s success in containing Ebola has been attributed, in part, to a Bill & Melinda Gates Foundation center established ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • Jef (an unusual nickname for Jennifer) got her master’s degree from Indiana University in April 2009 studying the mating behavior of seahorses. After four years of diving off the Gulf Coast of Tampa and performing behavioral experiments at the Tennessee Aquarium in Chattanooga, she left research to pursue a career in science writing. As The Scientist's managing editor, Jef edited features and oversaw the production of the TS Digest and quarterly print magazine. In 2022, her feature on uterus transplantation earned first place in the trade category of the Awards for Excellence in Health Care Journalism. She is a member of the National Association of Science Writers.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies